 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
TA Associates, a global growth private equity firm, has acquired a minority investment in Dr Lal PathLabs (LPL) by purchasing half of Sequoia Capitals stake
|
|
|
|
|
|
|
|
|
A new technology that tracks instruments and sponges during surgical procedures has earned clearance from the US Food and Drug Administration
|
|
|
|
|
|
|
| | |
For all your information needs on medtech and biomedical technology devices read BioSpectrum Asia. The portal is updated every morning with the latest biomedical technology news & articles, trends and analysis, business and investment opportunities, medtech research & development breakthroughs, product features, event listings and job postings.
| | | | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
CARD develops innovative therapy for Multiple Sclerosis
|
|
| Centre For Advanced Research and Development (CARD), of Scalene Cybernetics, a leader in innovative medical technologies is all set to make a pioneering contribution to the world of medicine for the treatment of Multiple Sclerosis |
|
|
|
|
|
Covidien sells Specialty Chemicals for $280 mn
|
|
| Covidien has announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million. |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
A business model for commercialization
|
|
| Governments, private sectors and academiaall talk about commercialization. Though their definitions vary, the end objectives are the same; the translation of a technology that has been validated beyond the academic environment. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
OvPlex: S Korea study begins for KFDA approval
|
|
| HealthLinx has finalized research agreements with its collaborators in South Korea to begin the 220 patient study required for South Korea Food and Drug Administration (KFDA) approval for the distribution of OvPlex. |
|
|
|
|
|
Study suggests up to 70% reduction in dose for PEM imaging
|
|
| In a recent study presented at the American Association of Physicists in Medicine Annual Meeting, researchers showed that 18FDG dose for Positron Emission Mammography (PEM) may be reduced by as much as 70 percent without altering image quality. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
